Novartis (NVS) Enterprise Value: 323.28B

Novartis AG (NVS)

153.81 +2.69 (+1.78%) USD | NYSE | Oct 26, 16:00

157.66 +3.85 (+2.50%) Pre-Market: 04:24

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2001. Start Trial.

Date	Value
October 26, 2026	323.28B
October 23, 2026	318.36B
October 22, 2026	327.79B
October 21, 2026	323.50B
October 20, 2026	322.97B
October 19, 2026	316.68B
October 16, 2026	317.45B
October 15, 2026	317.01B
October 14, 2026	310.60B
October 13, 2026	302.42B
October 12, 2026	305.03B
October 09, 2026	304.87B
October 08, 2026	303.70B
October 07, 2026	304.01B
October 06, 2026	299.45B
October 05, 2026	299.71B
October 02, 2026	299.84B
October 01, 2026	299.93B
September 30, 2026	302.71B
September 29, 2026	308.46B
September 28, 2026	310.60B
September 25, 2026	308.00B
September 24, 2026	304.54B
September 23, 2026	302.97B
September 22, 2026	300.35B

Date	Value
September 21, 2026	299.80B
September 18, 2026	298.68B
September 17, 2026	299.69B
September 16, 2026	295.63B
September 15, 2026	295.48B
September 14, 2026	296.16B
September 11, 2026	292.81B
September 10, 2026	293.39B
September 09, 2026	293.39B
September 08, 2026	293.79B
September 04, 2026	334.60B
September 03, 2026	340.27B
September 02, 2026	339.12B
September 01, 2026	336.90B
August 31, 2026	320.08B
August 28, 2026	323.28B
August 27, 2026	324.82B
August 26, 2026	330.11B
August 25, 2026	334.58B
August 24, 2026	330.99B
August 21, 2026	332.53B
August 20, 2026	327.73B
August 19, 2026	335.18B
August 18, 2026	324.64B
August 17, 2026	319.92B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks